ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019

ReShape Lifesciences Inc.

Companies Mentioned:

Primary Exchange: OTCQB
Under the Symbol: RSLS

ReShape Lifesciences to Host Third Quarter 2019 Conference Call on November 14, 2019

Thursday, November 7, 2019 5:30 PM

SAN CLEMENTE, CA / ACCESSWIRE / November 7, 2019 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases, today announced that it will host a conference call to discuss financial results for the third quarter of 2019 on Thursday, November 14, 2019 at 1:30 PM Pacific Time.

Individuals interested in listening to the conference call may do so by dialing (877) 280-7473 for domestic callers or (707) 287-9370 for international callers, using Conference ID: 1679507. To listen to a live webcast or a replay, please visit the investor relations section of the Company website at: ir.reshapelifesciences.com.

About ReShape Lifesciences Inc.

ReShape Lifesciences™ is a medical device company focused on technologies to treat obesity and metabolic diseases. The FDA-approved Lap-Band® Adjustable Gastric Banding System is designed to provide minimally invasive long-term treatment of severe obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest™ System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery, and is intended to enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.

Investor Contact:

Brendan O'Connell
VP Finance and Corporate Controller
ReShape Lifesciences Inc.
949-429-6680
[email protected]

or

Debbie Kaster
Investor Relations
Gilmartin Group
415-937-5403
[email protected]

SOURCE: ReShape Lifesciences Inc.


SHARE ARTICLE